Establishment Labs (ESTA) Revenue & Revenue Breakdown
Establishment Labs Revenue Highlights
Latest Revenue (Y)
$165.15M
Latest Revenue (Q)
$44.12M
Main Geography (Y)
EMEA
Establishment Labs Revenue by Period
Establishment Labs Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $165.15M | 2.13% |
2022-12-31 | $161.70M | 27.64% |
2021-12-31 | $126.68M | 49.61% |
2020-12-31 | $84.68M | -5.46% |
2019-12-31 | $89.56M | 46.33% |
2018-12-31 | $61.21M | 76.49% |
2017-12-31 | $34.68M | 75.15% |
2016-12-31 | $19.80M | - |
Establishment Labs Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $44.12M | 18.70% |
2024-03-31 | $37.17M | 17.77% |
2023-12-31 | $31.56M | -18.04% |
2023-09-30 | $38.51M | -20.71% |
2023-06-30 | $48.56M | 4.38% |
2023-03-31 | $46.52M | 6.19% |
2022-12-31 | $43.81M | 14.56% |
2022-09-30 | $38.24M | -7.15% |
2022-06-30 | $41.19M | 7.12% |
2022-03-31 | $38.45M | 8.89% |
2021-12-31 | $35.31M | 21.61% |
2021-09-30 | $29.04M | -9.24% |
2021-06-30 | $31.99M | 5.47% |
2021-03-31 | $30.34M | 12.51% |
2020-12-31 | $26.96M | 18.48% |
2020-09-30 | $22.76M | 117.28% |
2020-06-30 | $10.47M | -57.22% |
2020-03-31 | $24.48M | 0.96% |
2019-12-31 | $24.25M | 6.10% |
2019-09-30 | $22.85M | 5.40% |
2019-06-30 | $21.68M | 4.36% |
2019-03-31 | $20.78M | 26.72% |
2018-12-31 | $16.40M | 0.68% |
2018-09-30 | $16.29M | 18.80% |
2018-06-30 | $13.71M | -7.47% |
2018-03-31 | $14.82M | 25.44% |
2017-12-31 | $11.81M | 61.26% |
2017-09-30 | $7.32M | -15.10% |
2017-06-30 | $8.63M | 24.69% |
2017-03-31 | $6.92M | - |
Establishment Labs Revenue Breakdown
Establishment Labs Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Asia Pacific | $33.95M | - | - | - | - |
Other Geographical Areas | $2.16M | $994.00K | $865.00K | $511.00K | $540.00K |
Latin America | $48.89M | $52.44M | $38.23M | $21.51M | $27.99M |
EMEA | $80.15M | - | - | - | - |
Asia Pacific And Middle East | - | $59.56M | $35.68M | $24.99M | $24.82M |
Europe | - | $48.70M | $51.91M | $37.67M | $36.21M |
Quarterly Revenue by Country
Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Latin America | $7.91M | $8.37M | $12.58M | $16.32M | $11.62M | $13.75M | $12.32M | $14.18M | $12.19M | $13.26M | $9.79M | $7.17M | $8.00M | $7.80M | $5.21M | $1.37M | $7.14M | $6.40M | $9.41M | $6.02M |
Asia Pacific | $8.60M | $5.99M | $2.42M | $11.53M | $14.02M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Geographical Areas | $62.00K | $547.00K | $180.00K | $532.00K | $898.00K | $168.00K | $286.00K | $232.00K | $307.00K | $150.00K | - | $569.00K | $147.00K | $169.00K | $178.00K | $75.00K | $90.00K | $126.00K | $45.00K | $111.00K |
EMEA | $20.60M | $16.65M | $23.33M | $20.19M | $19.98M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Asia Pacific And Middle East | - | - | - | - | - | $17.61M | $16.92M | $13.41M | $11.62M | $8.34M | $8.12M | $9.73M | $9.49M | $6.94M | $7.69M | $2.88M | $7.47M | $7.75M | $5.85M | $6.28M |
Europe | - | - | - | - | - | $12.29M | $8.71M | $13.37M | $14.34M | $13.56M | $11.13M | $14.53M | $12.69M | $12.05M | $9.68M | $6.15M | $9.78M | $9.97M | $7.55M | $9.28M |
Establishment Labs Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ITGR | Integer | $1.60B | $746.27M |
CNMD | CONMED | $1.24B | $316.70M |
LIVN | LivaNova | $1.15B | $318.11M |
INGN | Inogen | $315.66M | $88.77M |
GKOS | Glaukos | $314.71M | $95.69M |
FNA | Paragon 28 | $216.39M | $61.02M |
ESTA | Establishment Labs | $165.15M | $44.12M |
KIDS | OrthoPediatrics | $148.73M | $52.80M |
SRDX | Surmodics | $132.58M | $30.34M |
SGHT | Sight Sciences | $81.06M | $21.37M |
LUNG | Pulmonx | $68.67M | $20.39M |
NPCE | NeuroPace | $65.42M | $18.12M |
APYX | Apyx Medical | $52.35M | $12.15M |
OSA | ProSomnus | $27.65M | $7.46M |
ESTA Revenue FAQ
What is Establishment Labs’s yearly revenue?
Establishment Labs's yearly revenue for 2023 was $165.15M, representing an increase of 2.13% compared to 2022. The company's yearly revenue for 2022 was $161.7M, representing an increase of 27.64% compared to 2021. ESTA's yearly revenue for 2021 was $126.68M, representing an increase of 49.61% compared to 2020.
What is Establishment Labs’s quarterly revenue?
Establishment Labs's quarterly revenue for Q2 2024 was $44.12M, a 18.70% increase from the previous quarter (Q1 2024), and a -9.15% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $37.17M, a 17.77% increase from the previous quarter (Q4 2023), and a -20.11% decrease year-over-year (Q1 2023). ESTA's quarterly revenue for Q4 2023 was $31.56M, a -18.04% decrease from the previous quarter (Q3 2023), and a -27.97% decrease year-over-year (Q4 2022).
What is Establishment Labs’s revenue growth rate?
Establishment Labs's revenue growth rate for the last 3 years (2021-2023) was 30.37%, and for the last 5 years (2019-2023) was 84.39%.